Eric Tousset
Eric Tousset
Verified email at - Homepage
Cited by
Cited by
“White coat compliance” limits the reliability of therapeutic drug monitoring in HIV-1—infected patients
TJ Podsadecki, BC Vrijens, EP Tousset, RA Rode, GJ Hanna
HIV clinical trials 9 (4), 238-246, 2008
Successful projection of the time course of drug concentration in plasma during a 1‐year period from electronically compiled dosing‐time data used as input to individually …
B Vrijens, E Tousset, R Rode, R Bertz, S Mayer, J Urquhart
The journal of clinical pharmacology 45 (4), 461-467, 2005
Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia
TJ Podsadecki, BC Vrijens, EP Tousset, RA Rode, GJ Hanna
Journal of infectious Diseases 196 (12), 1773-1778, 2007
Comparison of some modules of the Lie algebra of vector fields
PBA Lecomte, P Mathonet, E Tousset
Indagationes Mathematicae 7 (4), 461-471, 1996
Innovative ICT solutions to improve treatment outcomes for depression: the ICT4Depression project.
L Warmerdam, H Riper, MCA Klein, P van de Ven, A Rocha, ...
Annual review of cybertherapy and telemedicine 181 (1), 339-343, 2012
Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics
L Comté, B Vrijens, E Tousset, P Gérard, J Urquhart
Journal of pharmacokinetics and pharmacodynamics 34 (4), 549-558, 2007
Characterization of some aggregation functions stable for positive linear transformations
JL Marichal, P Mathonet, E Tousset
Fuzzy Sets and Systems 102 (2), 293-314, 1999
Effects on blood pressure and cardiovascular risk of variations in patients’ adherence to prescribed antihypertensive drugs: role of duration of drug action
A Lowy, VC Munk, SH Ong, M Burnier, B Vrijens, EP Tousset, J Urquhart
International journal of clinical practice 65 (1), 41-53, 2011
Management of patients with uncontrolled arterial hypertension–the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCT
T Mengden, H Vetter, E Tousset, S Uen
BMC Cardiovascular Disorders 6 (1), 1-9, 2006
Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE
R Düsing, R Handrock, S Klebs, E Tousset, B Vrijens
Journal of hypertension 27 (4), 894-901, 2009
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study
V Forni Ogna, M Pruijm, C Zweiacker, G Wuerzner, E Tousset, M Burnier
BioMed research international 2013, 2013
Cost-effectiveness of a nurse-based intervention (AIMS) to improve adherence among HIV-infected patients: design of a multi-centre randomised controlled trial
E Oberjé, M de Bruin, S Evers, W Viechtbauer, HE Nobel, H Schaalma, ...
BMC health services research 13 (1), 1-11, 2013
ICT4Depression: Service oriented architecture applied to the treatment of depression
A Rocha, MR Henriques, JC Lopes, R Camacho, M Klein, G Modena, ...
2012 25th IEEE International Symposium on Computer-Based Medical Systems …, 2012
A mobile system for treatment of depression
P van de Ven, MR Henriques, M Hoogendoorn, M Klein, E McGovern, ...
Computing Paradigms for Mental Health, 47, 2012
White coat compliance patterns make therapeutic drug monitoring (TDM) a potentially unreliable tool for assessing long-term drug exposure
T Podsadecki, B Vrijens, EP Tousset, RA Rode, GJ Hanna
13th Conference on Retroviruses and Opportunistic Infections, 5-8, 2006
Within-patient variance reduced in an ARV PK study by switching from patientreported to electronically-compiled dosing times
B Vrijens, E Tousset, R Rode, R Bertz, SL Mayer
Proceedings of the Second IAS Conference on HIV Pathogenesis and Treatment …, 2003
Mesures floues définies sur une échelle ordinale
JL Marichal, P Mathonet, E Tousset
working paper, 1996
Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre–Post …
A Leader, N Benyamini, A Gafter-Gvili, J Dreyer, B Calvarysky, A Amitai, ...
Clinical Lymphoma Myeloma and Leukemia 18 (11), e449-e461, 2018
Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimen
L Comté, S Vansteelandt, E Tousset, G Baxter, B Vrijens
Clinical Trials 6 (5), 403-415, 2009
Effect of long‐term adherence to clopidogrel on the VASP‐PRI after elective coronary stent implantation: a randomized controlled study
V Forni Ogna, I Menetrey, O Muller, E Tousset, L Guihard, P Fontana, ...
British journal of clinical pharmacology 82 (6), 1486-1497, 2016
The system can't perform the operation now. Try again later.
Articles 1–20